| |
| |
|
| Insider
Information: |
Bradbury Daniel |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
223,469 |
|
|
Indirect Shares
|
3,169,442 |
|
|
| Direct
Value |
$2,755,082 |
|
|
|
Indirect Value
|
$3,171,624 |
|
|
| Total
Shares |
3,392,911 |
|
|
| Total
Value |
$5,926,706 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amylin Pharmaceuticals Inc |
AMLN |
President & Chief Exec... |
2012-08-08 |
0 |
2012-08-08 |
0 |
Premium* |
|
|
Paratek Pharmaceuticals Inc |
PRTK |
Director |
2006-05-09 |
35,714 |
|
0 |
Premium* |
|
|
Illumina Inc |
ILMN |
Director |
2017-05-25 |
15,324 |
2008-05-16 |
0 |
Premium* |
|
|
Corcept Therapeutics Inc |
CORT |
Director |
2012-11-21 |
0 |
2019-02-07 |
130,575 |
Premium* |
|
|
Geron Corporation |
GERN |
Director |
2014-05-09 |
142,776 |
2019-03-29 |
51,323 |
Premium* |
|
|
Equillium Inc |
EQ |
Chief Executive Office... |
2018-10-16 |
0 |
2018-10-16 |
2,969,596 |
Premium* |
|
|
Castle Biosciences Inc |
CSTL |
Director |
2024-04-08 |
4,655 |
2024-04-08 |
17,948 |
Premium* |
|
|
Nuvation Bio Ord Shs Class A |
NUVB |
Director |
2021-02-10 |
25,000 |
2021-02-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2024-04-08 |
4 |
AS |
$20.45 |
$49,087 |
I/I |
(2,400) |
17,948 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2024-04-05 |
4 |
AS |
$20.86 |
$245,543 |
I/I |
(11,771) |
18,768 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2024-04-04 |
4 |
AS |
$21.45 |
$196,310 |
I/I |
(9,152) |
22,789 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2024-03-04 |
4 |
AS |
$20.44 |
$482,285 |
I/I |
(23,323) |
25,915 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2024-02-07 |
4 |
AS |
$23.20 |
$48,117 |
I/I |
(2,074) |
33,882 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2024-02-06 |
4 |
AS |
$23.63 |
$232,685 |
I/I |
(9,847) |
34,590 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2024-02-05 |
4 |
AS |
$22.74 |
$261,134 |
I/I |
(11,402) |
37,954 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2024-01-05 |
4 |
AS |
$20.36 |
$103,836 |
I/I |
(5,100) |
41,849 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2024-01-04 |
4 |
AS |
$20.40 |
$371,749 |
I/I |
(18,223) |
43,591 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-12-13 |
4 |
AS |
$20.04 |
$23,407 |
I/I |
(1,168) |
49,816 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-12-12 |
4 |
AS |
$20.01 |
$24,012 |
I/I |
(1,200) |
50,215 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-12-08 |
4 |
AS |
$20.09 |
$138,119 |
I/I |
(6,875) |
50,625 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-12-06 |
4 |
AS |
$20.02 |
$4,004 |
I/I |
(200) |
52,974 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-12-04 |
4 |
AS |
$20.08 |
$87,165 |
I/I |
(4,340) |
53,042 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-12-01 |
4 |
AS |
$20.06 |
$191,425 |
I/I |
(9,545) |
54,525 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-11-30 |
4 |
AS |
$20.08 |
$244,566 |
I/I |
(12,179) |
57,786 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-11-29 |
4 |
AS |
$20.13 |
$349,008 |
I/I |
(17,342) |
60,222 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-11-24 |
4 |
AS |
$20.02 |
$16,016 |
I/I |
(800) |
63,690 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-11-21 |
4 |
AS |
$20.00 |
$6,000 |
I/I |
(300) |
63,850 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-11-20 |
4 |
AS |
$20.04 |
$115,330 |
I/I |
(5,755) |
63,910 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-09-01 |
4 |
AS |
$20.04 |
$36,112 |
I/I |
(1,802) |
65,062 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-07-07 |
4 |
AS |
$20.39 |
$1,019,500 |
I/I |
(50,000) |
67,805 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-06-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,825 |
4,655 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-05-05 |
4 |
AS |
$21.12 |
$158,078 |
I/I |
(7,357) |
77,805 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-05-04 |
4 |
AS |
$21.29 |
$382,668 |
I/I |
(17,643) |
79,276 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
